{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T05:19:48Z","timestamp":1695791988774},"reference-count":55,"publisher":"Wiley","issue":"s2","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":3858,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mycoses"],"published-print":{"date-parts":[[1998,10]]},"abstract":"<jats:p><jats:bold>Zusammenfassung. <\/jats:bold> Im Verlauf invasiver Candidosen treten endogene <jats:italic>Candida<\/jats:italic>\u2010Endophthalmitiden (ECE) geh\u00e4uft auf und gehen mit einer erh\u00f6hten Mortalit\u00e4t einher. Bei Candid\u00e4mie\u2010Patienten wurde eine ECE\u2010Inzidenz von 28\u201337% berichtet. Bei <jats:italic>Candida<\/jats:italic>\u2010infizierten I.V.\u2010Drogenabh\u00e4ngigen betrug die Inzidenz 21%. Neben interventionellen Ma\u00dfnahmen, die bis hin zur Vitrektomie oder Enukleatio reichen k\u00f6nnen, ist die rechtzeitige Einleitung einer systemischen antimykotischen Therapie f\u00fcr den Ausgang entscheidend. Der klinische Einsatz von Fluconazol in der Therapie der ECE ist bei 96 Patienten und mindestens 108 Augen dokumentiert. Die mittlere Therapiedauer betrug 6\u20138 Wochen (maximale Behandlungsdauer: lebenslang) bei einer mittleren Dosis von 200\u2013400 mg\/d (maximale Dosis: 800 mg\/d bzw. 14 mg\/kg KG). Die in der Literatur berichteten Ergebnisse zeigen eine gute klinische Wirksamkeit von Fluconazol in der Behandlung der ECE: 90% Heilungsbzw. Besserungsrate (19\/21) bei Patienten mit\/ohne gleichzeitiger Vitrektomie bzw. mit\/ohne gleichzeitiger Gabe anderer Antimykotika, vollst\u00e4ndiges Verschwinden der L\u00e4sionen am Auge bei 94% (15\/16) nichtneutropenischer Candid\u00e4mie\u2010Patienten und bei 86% (6\/7) heroinabh\u00e4ngiger ECE\u2010Patienten. Fluconazol kann damit als Bestandteil der Standardtherapie der ECE angesehen werden.<\/jats:p><jats:p><jats:bold>Summary. <\/jats:bold> During the clinical course of invasive candidosis, endogenous <jats:italic>Candida<\/jats:italic> eudophthalmitis (ECE) is associated with a higher mortality. In patients with candidemia, an ECE\u2010incidence of 28 to 37% was reported. In I.V.\u2010drug users, the incidence of <jats:italic>Candida<\/jats:italic> infections was 21%. Besides surgical procedures including vitrectomy and enucleation, early initiation of systemic antifungal therapy is decisive for the outcome. The clinical use of fluconazole in ECE is documented in 96 patients and in a minimum of 108 eyes. The mean duration of therapy was 6\u20138 weeks (maximum duration: lifelong) with an average dosage of 200\u2013400 mg\/d (maximum dosage: 800 mg\/d and 14mg\/kg BW, resp.). The results reported in the literature show a good clinical efficacy of fluconazole in ECE: 90% response rate (19\/21) in patients with\/without concomitant vitrectomy and with\/without concomitant use of other antifungals, complete disappearance of all eye lesions in 94% (15\/16) nonneutropenic patients with candidemia and in 86% (6\/7) ECE\u2010patients addicted to heroin. With respect to these favorable results, fluconazole plays an important role in the standard therapy of ECE.<\/jats:p>","DOI":"10.1111\/j.1439-0507.1998.tb00600.x","type":"journal-article","created":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T16:55:50Z","timestamp":1240592150000},"page":"41-44","source":"Crossref","is-referenced-by-count":0,"title":["Der Stellenwert von Fluconazol in der Therapie der endogenen <i>Candida<\/i>\u2010Endophthalmitis"],"prefix":"10.1111","volume":"41","author":[{"given":"A. Penk und L.","family":"Pittrow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01962067"},{"key":"e_1_2_1_3_2","first-page":"15","article-title":"Predominant pathogens in hospital infections.","volume":"28","author":"Jarvis W. R.","year":"1992","journal-title":"J Antimicrob Chemother"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/167.5.1247"},{"issue":"3","key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0002-9343(91)90349-3","article-title":"Secular trends in nosocomial primary bloodstream infections in the United States, 1980\u20131989.","volume":"89","author":"Banerjee S. N.","year":"1991","journal-title":"Am J Med"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1988.00380120094019"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197401000-00002"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/archinte.1994.00420180103012","article-title":"Mortality of hospitalized patients with candida endophthaimitis.","volume":"154","author":"Menezes A. V.","year":"1994","journal-title":"Arch Intern Med"},{"key":"e_1_2_1_9_2","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1001\/archinte.1989.00390100056014","article-title":"Prospective study of candida endophthalmitis in hospitalized patients with candidemia.","volume":"149","author":"Brooks R. G.","year":"1989","journal-title":"Arch Intern Med"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(82)34722-3"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(97)30091-8"},{"key":"e_1_2_1_12_2","first-page":"2021","article-title":"Successful treatment of endogenous fungal endophthalmitis with fluconazole therapy.","volume":"41","author":"Yura A.","year":"1990","journal-title":"Folia Ophthalmol Jpn"},{"key":"e_1_2_1_13_2","first-page":"1389","article-title":"Systemic fluconazole for endogenous fungal endophthalmitis.","volume":"45","author":"Kaneko S.","year":"1991","journal-title":"Jpn J Clin Ophthalmol"},{"key":"e_1_2_1_14_2","first-page":"1530","article-title":"Two cases of Candida endophthalmitis healed following intravitreal miconazole and systemic fluconazole.","volume":"84","author":"Tanigucchi S.","year":"1990","journal-title":"Jpn Rev Clin Ophthalmol"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)71537-5"},{"key":"e_1_2_1_16_2","first-page":"105","article-title":"Uveo\u2010papillite \u00e0Candida albicans. Discussion diagnostique et th\u00e9rapeuticue a propos d'une observation.","volume":"1","author":"Despress E.","year":"1990","journal-title":"Bull Sec Ophthalmol Fr"},{"key":"e_1_2_1_17_2","first-page":"55","article-title":"Fluconazole treatment for systemic mycoses.","volume":"42","author":"Mori T.","year":"1989","journal-title":"Jpn J Antibiot"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/25.4.718"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1046113"},{"key":"e_1_2_1_20_2","first-page":"81","article-title":"A case of fungal endophthalmitis after cataract and intraocular lens implant surgery.","volume":"5","author":"Imai M.","year":"1991","journal-title":"IOL"},{"key":"e_1_2_1_21_2","first-page":"651","article-title":"Studies on endogenous fungal endophthalmitis occurring during the serious infections of liver and bile duct systems.","volume":"53","author":"Hideshima T.","year":"1991","journal-title":"Surgery"},{"key":"e_1_2_1_22_2","first-page":"1833","article-title":"Five cases of endogenous Candida endophthalmitis.","volume":"7","author":"Suzuki I.","year":"1991","journal-title":"J Eye"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/14.2.422"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.1992.tb02126.x"},{"key":"e_1_2_1_25_2","first-page":"1103","article-title":"Chorioretinitis caused by Candida albicans with systemic candidiasis in a patient with acquired immunodeficiency syndrome: Results of a treatment with fluconazole.","volume":"49","author":"Fera G.","year":"1991","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1993.tb00749.x"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1035095"},{"key":"e_1_2_1_28_2","first-page":"387","article-title":"Chorior\u00e9tinite candidosique chez les toxicomanes. A propos de 2 cas.","volume":"21","author":"Le Thien L.","year":"1998","journal-title":"J Fr Ophthalmol"},{"key":"e_1_2_1_29_2","first-page":"807","article-title":"A case of acute multifocal retinitis.","volume":"81","author":"Takada Y.","year":"1998","journal-title":"Jpn J Clin Ophthalmol"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01708625"},{"key":"e_1_2_1_31_2","first-page":"477","article-title":"Treatment of ocular fungal infections with oral fluconazole.","volume":"119","author":"Luttrul J. K.","year":"1994","journal-title":"Am J Ophthal"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/20.3.657"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01691319"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1993.tb00681.x"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-199803000-00017"},{"key":"e_1_2_1_36_2","first-page":"320","article-title":"Asymptomatic vaso\u2010occlusive retinopathy in Hughes' syndrome.","volume":"2","author":"Geh V.S. y.","year":"1998","journal-title":"Eye"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1993.01090100032019"},{"key":"e_1_2_1_38_2","first-page":"153","article-title":"Efficacy of fluconazole treatment of candidal endophthalmtiis in two heroin addicts (letter).","volume":"9","author":"Carnevali\u2010Ruiz D.","year":"1992","journal-title":"An Med Interna"},{"key":"e_1_2_1_39_2","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3928\/1542-8877-19961201-07","article-title":"Vitrectomy and systemic fluconazole for treatment of endogenous fungal endophthalmitis.","volume":"27","author":"Christmas N.J.","year":"1996","journal-title":"Ophthalmic Surg Lasers"},{"key":"e_1_2_1_40_2","first-page":"239","article-title":"Endogenous Candida endophthalmitis: A case report.","volume":"53","author":"Chung Y.M.","year":"1994","journal-title":"Chung Hua I Hsueh Tsa Chih Taipei"},{"key":"e_1_2_1_41_2","first-page":"105","article-title":"Candida albicans uveopapillitis. Diagnostic and therapeutic discussion a propos of a case.","volume":"90","author":"Despres E.","year":"1990","journal-title":"Bull Soc Ophthalmol Fr"},{"key":"e_1_2_1_42_2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3928\/1542-8877-19970301-03","article-title":"Treatment outcomes in a 10\u2010year study of endogenous fungal endophthalmitis.","volume":"28","author":"Essman T.F.","year":"1997","journal-title":"Ophthalmic Surg Lasers"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-199503000-00018"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1159\/000310392"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/17.5.888"},{"key":"e_1_2_1_46_2","first-page":"864","article-title":"Congenital Candida Infections.","volume":"141","author":"Schlosser R. L.","year":"1993","journal-title":"Monatsschr Kinderheilkd"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01781109"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1997.01100150672022"},{"key":"e_1_2_1_49_2","first-page":"583","article-title":"Vitreous surgery for mycotic endophthalmitis.","volume":"68","author":"Yokoi M.","year":"1993","journal-title":"Hokkaido Igaku Zasshi"},{"key":"e_1_2_1_50_2","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3928\/1542-8877-19960701-12","article-title":"Treatment of presumed fungal endophthalmitis with oral fluconazole.","volume":"27","author":"Zarbin M. A.","year":"1996","journal-title":"Ophthalmic Surg Lasers"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411173312001"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.1.6"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.4.958"},{"key":"e_1_2_1_54_2","first-page":"1479","article-title":"Ocular penetration of fluconazole.","volume":"8","author":"Abe M.","year":"1991","journal-title":"J Fye"},{"key":"e_1_2_1_55_2","first-page":"829","article-title":"Fluconazolspiegei im Kammerwasser nach oraler Wirkstoffgabe beim Menschen.","volume":"92","author":"Aust R.","year":"1995","journal-title":"Ophthalmologe"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1076\/ceyr.16.9.930.5042"}],"container-title":["Mycoses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1439-0507.1998.tb00600.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1439-0507.1998.tb00600.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T04:54:31Z","timestamp":1695704071000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1439-0507.1998.tb00600.x"}},"subtitle":["Standing of fluconazole in the therapy of endogenous <i>Candida<\/i> endophthalmitis"],"short-title":[],"issued":{"date-parts":[[1998,10]]},"references-count":55,"journal-issue":{"issue":"s2","published-print":{"date-parts":[[1998,10]]}},"alternative-id":["10.1111\/j.1439-0507.1998.tb00600.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1439-0507.1998.tb00600.x","archive":["Portico"],"relation":{},"ISSN":["0933-7407","1439-0507"],"issn-type":[{"value":"0933-7407","type":"print"},{"value":"1439-0507","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,10]]}}}